{Reference Type}: Journal Article
{Title}: Diagnostic performance of the CellaVision preclassification neutrophil count - time to bypass the reclassification?
{Author}: Christiansen M;Abildgaard A;Larsen JB;Tindbæk G;Vestergaard EM;
{Journal}: Scand J Clin Lab Invest
{Volume}: 0
{Issue}: 0
{Year}: 2024 Jul 11
{Factor}: 2.209
{DOI}: 10.1080/00365513.2024.2377967
{Abstract}: <B>UNASSIGNED: </B>The objective of this study was to perform a method comparison between the CellaVision preclassification neutrophil count and the reclassification neutrophil count performed by trained laboratory technicians, and to evaluate the diagnostic performance of the preclassification neutrophil count at clinical decision levels.<BR><B>UNASSIGNED: </B>We retrospectively identified patient samples through 2019-2022 in which the differential count was performed on Cellavision (n = 4,354). Data on sample characteristics and leukocyte- and differential counts was extracted from the electronic medical journal. For each sample, data containing the pre- and reclassification leukocyte classification, respectively, was extracted from the Cellavision software. Method comparison between the pre-and reclassification neutrophil count was performed using Bland Altman analysis. Diagnostic performance of the preclassification neutrophil count was evaluated according to four pre-specified categories of results with the reclassification as reference method.<BR><B>UNASSIGNED: </B>The median difference between the pre- and reclassification neutrophil count was 0.044 x 109/L. The preclassification neutrophil count categorised 95.6% of all samples correctly according to the four categories. The sensitivity, specificity, positive predictive value and negative predictive value for detecting neutrophilia > 7.00 x 109/L was 98.8%, 97.2%, 95.8%, and 99.2%, respectively. In samples with leukopenia (n = 543), the sensitivity, specificity, positive predictive value and negative predictive value for detecting severe neutropenia (< 0.50 x 109/L) was 97.7%, 99.1%, 98.6%, and 98.5%, respectively.<BR><B>UNASSIGNED: </B>The diagnostic performance of the CellaVision preclassification neutrophil count was satisfactory. The preclassification neutrophil count may be released to the electronic medical journal to improve turnaround time and benefit laboratory management.